Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Digestive System Diseases; Neoplasms | 0.020 | 1.000 | 2 | 2014 | 2018 | |||||||
|
1.000 | 0.080 | 12 | 130876170 | 3 prime UTR variant | A/C;G | snv |
|
Digestive System Diseases; Neoplasms | 0.020 | 0.500 | 2 | 2013 | 2017 | ||||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Digestive System Diseases; Neoplasms | 0.010 | < 0.001 | 1 | 2016 | 2016 | |||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Nervous System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Endocrine System Diseases; Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Eye Diseases | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 | |||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
0.010 | 1.000 | 1 | 2018 | 2018 | ||||||||
|
0.742 | 0.320 | 12 | 130876696 | 3 prime UTR variant | C/T | snv | 0.33 |
|
Digestive System Diseases; Neoplasms | 0.010 | 1.000 | 1 | 2015 | 2015 |